Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 29.58
-2.28 %
$ 954 M
Market Cap
12.64
P/E
Price Target
Average
44.81%
Revenue Forecast
Estimate
3.72%
EBIT
Estimate
--19.78%
Net Income
Estimate
76.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Collegium Pharmaceutical, Inc.
Wall Street analysts predict an average 1-year price target for COLL of $42.8 , with forecasts ranging from a low of $37 to a high of $50 .
COLL Lowest Price Target
Wall Street Target
37 USD
25.08%
COLL Average Price Target
Wall Street Target
42.8 USD
44.81%
COLL Highest Price Target
Wall Street Target
50 USD
69.03%
REVENUE FORECAST
Revenue Forecast Chart COLL
EBIT FORECAST
EBIT Forecast Chart COLL
NET INCOME FORECAST
Net Income Chart COLL